Literature DB >> 32485136

CD49f Is a Novel Marker of Functional and Reactive Human iPSC-Derived Astrocytes.

Lilianne Barbar1, Tanya Jain1, Matthew Zimmer1, Ilya Kruglikov1, Jessica S Sadick2, Minghui Wang3, Kriti Kalpana1, Indigo V L Rose2, Suzanne R Burstein1, Tomasz Rusielewicz1, Madhura Nijsure1, Kevin A Guttenplan4, Angelique di Domenico1, Gist Croft1, Bin Zhang3, Hiroko Nobuta5, Jean M Hébert5, Shane A Liddelow6, Valentina Fossati7.   

Abstract

New methods for investigating human astrocytes are urgently needed, given their critical role in the central nervous system. Here we show that CD49f is a novel marker for human astrocytes, expressed in fetal and adult brains from healthy and diseased individuals. CD49f can be used to purify fetal astrocytes and human induced pluripotent stem cell (hiPSC)-derived astrocytes. We provide single-cell and bulk transcriptome analyses of CD49f+ hiPSC-astrocytes and demonstrate that they perform key astrocytic functions in vitro, including trophic support of neurons, glutamate uptake, and phagocytosis. Notably, CD49f+ hiPSC-astrocytes respond to inflammatory stimuli, acquiring an A1-like reactive state, in which they display impaired phagocytosis and glutamate uptake and fail to support neuronal maturation. Most importantly, we show that conditioned medium from human reactive A1-like astrocytes is toxic to human and rodent neurons. CD49f+ hiPSC-astrocytes are thus a valuable resource for investigating human astrocyte function and dysfunction in health and disease.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  A1 reactive astrocytes; CD49f; FACS purification; astrocytes; induced pluripotent stem cells; neurodegeneration; neurotoxicity

Mesh:

Substances:

Year:  2020        PMID: 32485136      PMCID: PMC8274549          DOI: 10.1016/j.neuron.2020.05.014

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  70 in total

1.  Integrin alpha 6 regulates glioblastoma stem cells.

Authors:  Justin D Lathia; Joseph Gallagher; John M Heddleston; Jialiang Wang; Christine E Eyler; Jennifer Macswords; Qiulian Wu; Amit Vasanji; Roger E McLendon; Anita B Hjelmeland; Jeremy N Rich
Journal:  Cell Stem Cell       Date:  2010-05-07       Impact factor: 24.633

2.  Automated, high-throughput derivation, characterization and differentiation of induced pluripotent stem cells.

Authors:  Daniel Paull; Ana Sevilla; Hongyan Zhou; Aana Kim Hahn; Hesed Kim; Christopher Napolitano; Alexander Tsankov; Linshan Shang; Katie Krumholz; Premlatha Jagadeesan; Chris M Woodard; Bruce Sun; Thierry Vilboux; Matthew Zimmer; Eliana Forero; Dorota N Moroziewicz; Hector Martinez; May Christine V Malicdan; Keren A Weiss; Lauren B Vensand; Carmen R Dusenberry; Hannah Polus; Karla Therese L Sy; David J Kahler; William A Gahl; Susan L Solomon; Stephen Chang; Alexander Meissner; Kevin Eggan; Scott A Noggle
Journal:  Nat Methods       Date:  2015-08-03       Impact factor: 28.547

Review 3.  Astrocytes in neurodegenerative disease.

Authors:  Hemali Phatnani; Tom Maniatis
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-04-15       Impact factor: 10.005

4.  featureCounts: an efficient general purpose program for assigning sequence reads to genomic features.

Authors:  Yang Liao; Gordon K Smyth; Wei Shi
Journal:  Bioinformatics       Date:  2013-11-13       Impact factor: 6.937

5.  Directed differentiation of functional astroglial subtypes from human pluripotent stem cells.

Authors:  Robert Krencik; Su-Chun Zhang
Journal:  Nat Protoc       Date:  2011-10-13       Impact factor: 13.491

6.  Multiple and novel specificities of monoclonal antibodies O1, O4, and R-mAb used in the analysis of oligodendrocyte development.

Authors:  R Bansal; A E Warrington; A L Gard; B Ranscht; S E Pfeiffer
Journal:  J Neurosci Res       Date:  1989-12       Impact factor: 4.164

Review 7.  Astrocytes: biology and pathology.

Authors:  Michael V Sofroniew; Harry V Vinters
Journal:  Acta Neuropathol       Date:  2009-12-10       Impact factor: 17.088

Review 8.  Drug screening for human genetic diseases using iPSC models.

Authors:  Matthew S Elitt; Lilianne Barbar; Paul J Tesar
Journal:  Hum Mol Genet       Date:  2018-08-01       Impact factor: 6.150

9.  Glial fibrillary acidic protein (GFAP) in ependymal cells during development. An immunocytochemical study.

Authors:  U Roessmann; M E Velasco; S D Sindely; P Gambetti
Journal:  Brain Res       Date:  1980-10-27       Impact factor: 3.252

10.  Efficient generation of myelinating oligodendrocytes from primary progressive multiple sclerosis patients by induced pluripotent stem cells.

Authors:  Panagiotis Douvaras; Jing Wang; Matthew Zimmer; Stephanie Hanchuk; Melanie A O'Bara; Saud Sadiq; Fraser J Sim; James Goldman; Valentina Fossati
Journal:  Stem Cell Reports       Date:  2014-07-24       Impact factor: 7.765

View more
  42 in total

Review 1.  Human stem cell models of neurodegeneration: From basic science of amyotrophic lateral sclerosis to clinical translation.

Authors:  Elisa Giacomelli; Björn F Vahsen; Elizabeth L Calder; Yinyan Xu; Jakub Scaber; Elizabeth Gray; Ruxandra Dafinca; Kevin Talbot; Lorenz Studer
Journal:  Cell Stem Cell       Date:  2022-01-06       Impact factor: 24.633

2.  Complement component 3 from astrocytes mediates retinal ganglion cell loss during neuroinflammation.

Authors:  Marjan Gharagozloo; Matthew D Smith; Jing Jin; Thomas Garton; Michelle Taylor; Alyssa Chao; Keya Meyers; Michael D Kornberg; Donald J Zack; Joan Ohayon; Brent A Calabresi; Daniel S Reich; Charles G Eberhart; Carlos A Pardo; Claudia Kemper; Katharine A Whartenby; Peter A Calabresi
Journal:  Acta Neuropathol       Date:  2021-09-06       Impact factor: 17.088

Review 3.  Astrocyte polarization in glaucoma: a new opportunity.

Authors:  Yi-Xin Liu; Hao Sun; Wen-Yi Guo
Journal:  Neural Regen Res       Date:  2022-12       Impact factor: 6.058

4.  Astrocytes and oligodendrocytes undergo subtype-specific transcriptional changes in Alzheimer's disease.

Authors:  Jessica S Sadick; Michael R O'Dea; Philip Hasel; Taitea Dykstra; Arline Faustin; Shane A Liddelow
Journal:  Neuron       Date:  2022-04-04       Impact factor: 18.688

5.  Potential role of chitinase-3-like protein 1 (CHI3L1/YKL-40) in neurodegeneration and Alzheimer's disease.

Authors:  Kevin Connolly; Mikael Lehoux; Ryan O'Rourke; Benedetta Assetta; Guzide Ayse Erdemir; Jack A Elias; Chun Geun Lee; Yu-Wen Alvin Huang
Journal:  Alzheimers Dement       Date:  2022-03-02       Impact factor: 16.655

6.  The smoothened agonist SAG reduces mitochondrial dysfunction and neurotoxicity of frataxin-deficient astrocytes.

Authors:  Andrés Vicente-Acosta; Alfredo Giménez-Cassina; Javier Díaz-Nido; Frida Loria
Journal:  J Neuroinflammation       Date:  2022-04-12       Impact factor: 8.322

7.  Differential expression of tau species and the association with cognitive decline and synaptic loss in Alzheimer's disease.

Authors:  Sivaprakasam R Saroja; Abhijeet Sharma; Patrick R Hof; Ana C Pereira
Journal:  Alzheimers Dement       Date:  2021-12-07       Impact factor: 16.655

8.  Osteopontin/secreted phosphoprotein-1 behaves as a molecular brake regulating the neuroinflammatory response to chronic viral infection.

Authors:  Farina J Mahmud; Yong Du; Elizabeth Greif; Thomas Boucher; Robert F Dannals; William B Mathews; Martin G Pomper; Polina Sysa-Shah; Kelly A Metcalf Pate; Claire Lyons; Bess Carlson; Maria Chacona; Amanda M Brown
Journal:  J Neuroinflammation       Date:  2020-09-17       Impact factor: 8.322

9.  Long Noncoding RNA X-Inactive-Specific Transcript Promotes the Secretion of Inflammatory Cytokines in LPS Stimulated Astrocyte Cell Via Sponging miR-29c-3p and Regulating Nuclear Factor of Activated T cell 5 Expression.

Authors:  Mengqi Zhang; Haojun Yang; Zhuohui Chen; Xinhang Hu; Tong Wu; Weiping Liu
Journal:  Front Endocrinol (Lausanne)       Date:  2021-03-12       Impact factor: 5.555

Review 10.  An Overview of Astrocyte Responses in Genetically Induced Alzheimer's Disease Mouse Models.

Authors:  Fokion Spanos; Shane A Liddelow
Journal:  Cells       Date:  2020-11-04       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.